Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI) Pfizer Inc

23rd May 2014 10:55

RNS Number : 9313H
Morgan Stanley Capital Services LLC
23 May 2014
 



 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PFIZER INC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

22 MAY 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 COMMON STOCK

 PURCHASES

 135,701

 29.8502 USD

 29.6141 USD

 COMMON STOCK

 SALES

 110,960

 29.8600 USD

 29.5900 USD

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 COMMON STOCK

 CFD

 LONG

 25,000

 29.6600 USD

 COMMON STOCK

 CFD

 LONG

 22,000

 29.6695 USD

 COMMON STOCK

 CFD

 LONG

 76

 29.6700 USD

 COMMON STOCK

 CFD

 LONG

 58

 29.6700 USD

 COMMON STOCK

 CFD

 LONG

 1,200

 29.6895 USD

 COMMON STOCK

 CFD

 LONG

 22,400

 29.7387 USD

 COMMON STOCK

 CFD

 LONG

 400

 29.7550 USD

 COMMON STOCK

 CFD

 LONG

 4,400

 29.7681 USD

 COMMON STOCK

 CFD

 LONG

 7,300

 29.7691 USD

 COMMON STOCK

 CFD

 LONG

 2,258

 29.7697 USD

 COMMON STOCK

 CFD

 LONG

 500

 29.7840 USD

 COMMON STOCK

 CFD

 LONG

 3,600

 29.7868 USD

 COMMON STOCK

 CFD

 SHORT

 500

 29.6500 USD

 COMMON STOCK

 CFD

 SHORT

 2,800

 29.6600 USD

 COMMON STOCK

 CFD

 SHORT

 3,600

 29.6795 USD

 COMMON STOCK

 CFD

 SHORT

 110

 29.6929 USD

 COMMON STOCK

 CFD

 SHORT

 1,213

 29.6930 USD

 COMMON STOCK

 CFD

 SHORT

 29,900

 29.7048 USD

 COMMON STOCK

 CFD

 SHORT

 2

 29.7250 USD

 COMMON STOCK

 CFD

 SHORT

 87,063

 29.7292 USD

 COMMON STOCK

 CFD

 SHORT

 400

 29.7325 USD

 COMMON STOCK

 CFD

 SHORT

 667

 29.7588 USD

 COMMON STOCK

 CFD

 SHORT

 102

 29.7588 USD

 COMMON STOCK

 CFD

 SHORT

 1,900

 29.7600 USD

 COMMON STOCK

 CFD

 SHORT

 11

 29.7627 USD

 COMMON STOCK

 CFD

 SHORT

 10

 29.7650 USD

 COMMON STOCK

 CFD

 SHORT

 10

 29.7650 USD

 COMMON STOCK

 CFD

 SHORT

 17

 29.7665 USD

 COMMON STOCK

 CFD

 SHORT

 2

 29.7800 USD

 COMMON STOCK

 CFD

 SHORT

 1,800

 29.7827 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

23 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGCGDUSUDBGSX

Related Shares:

AstrazenecaPFZ.L
FTSE 100 Latest
Value8,680.29
Change47.96